Anavex Life Sciences Corp.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Anavex Life Sciences Corp. now
Current reporting with the operating signal separated from the noise.
Anavex Life Sciences Corp (AVXL) Valuation: PE, PB & Fair Value Analysis
The development tests whether Anavex Life Sciences Corp. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement
The story matters when it changes Anavex Life Sciences Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Anavex Life Sciences Corp reports results for the quarter ended March 31 - Earnings Summary
Investors are testing whether Anavex Life Sciences Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Anavex Life Sciences Corp (AVXL) Institutional Confidence
The story matters when it changes Anavex Life Sciences Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.AVXL|Anavex Life Sciences Corp|Price:2.750|Chg%:+0.050
The story matters when it changes Anavex Life Sciences Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk
The story matters when it changes Anavex Life Sciences Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2026 Earnings Call Transcript
Investors are testing whether Anavex Life Sciences Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Anavex Life Sciences Corp. (AVXL) Q4 2025 Earnings Call Transcript
Investors are testing whether Anavex Life Sciences Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2025 Earnings Call Transcript
Investors are testing whether Anavex Life Sciences Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Anavex Life Sciences Corp. to Announce Second Fiscal Quarter Financial Results on May 13, 2025
The story matters when it changes Anavex Life Sciences Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Anavex Life Sciences Corp. (AVXL) Q1 2025 Earnings Call Transcript
Investors are testing whether Anavex Life Sciences Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Anavex Life Sciences Corp. Announces Financial Results Conference Call for First Fiscal Quarter 2025
The story matters when it changes Anavex Life Sciences Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest AVXL filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Anavex Life Sciences Corp., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →